Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial

Andrew W. Creamer, Shaney L. Barratt

Source: Breathe, 15 (2) 140; 10.1183/20734735.0002-2019
Journal Issue: June
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Andrew W. Creamer, Shaney L. Barratt. Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial. Breathe, 15 (2) 140; 10.1183/20734735.0002-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: